6’,7’-Epoxybergamottin Reference: 19760-5 A potent CYP3A4 inhibitor (IC50s = 0.30 ppm in a cell-free assay, 0.33 µM in HL7 human liver cells, and 0.22 µM in S9 human intestine cells); inhibits the transport of talinolol, a P-gp/ABCB1 transporter substrate, across Caco-2 cell monolayers (IC50 = 0.7 µM); has insecticidal properties (5 µg/cm2 leads to 100% mortality of adult olive fruit flies)
5-Chlororesorcinol dimethyl ether Reference: 10007127-25 5-Chloroesorcinol dimethyl ether is a synthetic intermediate useful for pharmaceutical synthesis.
Cysteinyl Leukotriene HPLC Mixture I Reference: 20001-1 This mixture contains all of the primary cysteinyl-leukotrienes derived from arachidonic acid. Contents: Leukotriene C4, Leukotriene D4, Leukotriene E4, Leukotriene F4, and N-acetyl Leukotriene E4 (5 µg each).
5-Chlororesorcinol dimethyl ether Reference: 10007127-5 5-Chloroesorcinol dimethyl ether is a synthetic intermediate useful for pharmaceutical synthesis.
Cysteinyl Leukotriene HPLC Mixture II Reference: 20002-1 This mixture contains all primary cysteinyl leukotrienes derived from arachidonic acid and also includes Prostaglandin B2. Contents: Leukotriene C4, Leukotriene D4, Leukotriene E4, Leukotriene F4, N-acetyl Leukotriene E4 (5 µg each) and Prostaglandin B2 (10 µg).
5-Chlororesorcinol dimethyl ether Reference: 10007127-50 5-Chloroesorcinol dimethyl ether is a synthetic intermediate useful for pharmaceutical synthesis.
threo-9,10-Dihydroxyhexadecanoic acid, mg Reference: 14-1627 Synonyms: 9,10-Dihydroxypalmitic acid; (±)-threo-9,10-Dihydroxyhexadecanoic acid